Judge in federal opioid trial says he won’t recuse himself

The judge overseeing the federal opioid trial said he will not recuse himself from the case, denying the defendants’ claim that he is biased, according to The Washington Post.

Advertisement

Lawyers representing the drug companies filed a motion Sept. 14 asking U.S. District Judge Dan Polster to recuse himself, claiming comments he made in and out of court showed he was biased toward wanting defendants to settle the case.

If drugmakers and distributors agreed to a settlement, they would have to spend money to fund addiction treatment and other aid for the affected communities.

In a written ruling, Mr. Polster said acknowledging the toll of the opioid epidemic does not make him biased, it makes him “human.”

He also said it was impractical to expect another judge to be able to take over the lawsuit, which The Washington Post said could be the most complicated civil lawsuit in history, just weeks before it is set to begin.

Read the full article here.

More articles on opioids:

Ineffective drug rehab often costs families thousands
These 3 factors will define nurses’ roles in fighting the opioid epidemic
Penn Medicine center blends radiology, psychiatry for precision approach to opioid treatment

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.